UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 259

Sortiert nach

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

British journal of cancer, 2006-02, Vol.94 (4), p.524-531

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

Investigational new drugs, 2017-12, Vol.35 (6), p.766-772

2017

Link zum Volltext

Verfügbarkeit prüfen

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia cachexia: a randomised, placebo-controlled, double-blind, double-crossover study

British journal of cancer, 2008-01, Vol.98 (2), p.300-308

2008

Link zum Volltext

Verfügbarkeit prüfen

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Annals of oncology, 2008-07, Vol.19 (7), p.1288-1292

2008

Link zum Volltext

Verfügbarkeit prüfen

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Annals of oncology, 2009-09, Vol.20 (9), p.1522-1528

2009

Link zum Volltext

Verfügbarkeit prüfen

Cost of skeletal complications from bone metastases in six European countries

Journal of medical economics, 2016-06, Vol.19 (6), p.611-618

2016

Link zum Volltext

Verfügbarkeit prüfen

Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib

Annals of oncology, 2009-09, Vol.20 (9), p.1606-1607

2009

Link zum Volltext

Verfügbarkeit prüfen

Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment

Annals of oncology, 2006-05, Vol.17 (5), p.801-806

2006

Link zum Volltext

Verfügbarkeit prüfen

The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)

Annals of oncology, 2016-02, Vol.27 (2), p.324-332

2016

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Annals of oncology, 2015-04, Vol.26 (4), p.709-714

2015

Link zum Volltext

Verfügbarkeit prüfen

Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours

British journal of cancer, 2014-08, Vol.111 (4), p.651-659

2014

Link zum Volltext

Verfügbarkeit prüfen

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Annals of oncology, 2018-06, Vol.29 (6), p.1423-1430

2018

Link zum Volltext

Verfügbarkeit prüfen

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy

Annals of oncology, 2023-08, Vol.34 (8), p.638-644

2023

Link zum Volltext

Verfügbarkeit prüfen

Quality of life in patients treated with aflibercept and FOLFIRI for metastatic colorectal cancer: interim analysis with focus on therapy lines of the non-interventional study QoLiTrap (AIO-LQ-0113)

Annals of oncology, 2019-07, Vol.30, p.iv118-iv118

2019

Link zum Volltext

Verfügbarkeit prüfen

Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03)

Endocrine-related cancer, 2011-04, Vol.18 (2), p.257-264

2011

Link zum Volltext

Verfügbarkeit prüfen

Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)

Annals of oncology, 2020-04, Vol.31 (4), p.495-500

2020

Link zum Volltext

Verfügbarkeit prüfen

Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study

Annals of oncology, 2008-07, Vol.19 (7), p.1266-1270

2008

Link zum Volltext

Verfügbarkeit prüfen

Absence of evidence is not evidence of absence: the case of non-inferiority

Annals of oncology, 2017-12, Vol.28 (12), p.3100-3101

2017

Link zum Volltext

Verfügbarkeit prüfen

Interim analysis of the non-interventional study QoLiTrap (AIO-LQ-0113) in patients with metastatic colorectal cancer (mCRC) treated with aflibercept (AFL) + FOLFIRI: Efficacy according to age group ≤65 and >65 years

Annals of oncology, 2018-10, Vol.29, p.viii192-viii192

2018

Link zum Volltext

Verfügbarkeit prüfen

Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis

British journal of cancer, 2005-10, Vol.93 (7), p.793-798

2005

Link zum Volltext

Verfügbarkeit prüfen

Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap

Annals of oncology, 2018-06, Vol.29, p.v73-v73

2018

Link zum Volltext

Verfügbarkeit prüfen

Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort

Annals of oncology, 2014-08, Vol.25 (8), p.1591-1597

2014

Link zum Volltext

Verfügbarkeit prüfen

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

European journal of cancer (1990), 2009-09, Vol.45 (13), p.2293-2297

2009

Link zum Volltext

Verfügbarkeit prüfen

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

Annals of oncology, 2018-03, Vol.29 (3), p.661-668

2018

Link zum Volltext

Verfügbarkeit prüfen

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

Annals of oncology, 2012-02, Vol.23 (2), p.531-536

2012

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 259

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(241)
Mit Volltextzugriff
(242)

Publikationsform

Sprache

Englisch
(228)
Deutsch
(30)
Japanisch
(5)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(74)
Humans
(73)
Oncology
(52)
Female
(49)
Middle Aged
(45)
Male
(41)
Aged
(40)
Adult
(29)
Biological And Medical Sciences
(24)
Hematology, Oncology And Palliative Medicine
(24)
Medical Sciences
(23)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(22)
Tumors
(22)
Aged, 80 And Over
(17)
Antineoplastic Agents
(15)
Treatment Outcome
(15)
Pharmacology. Drug Treatments
(14)
Breast Cancer
(13)
Breast Neoplasms - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Circulating endothelial cells and angiogenic serum factors during neoadjuvant chemotherapy of primary breast cancer

Phase I trial of the oral smoothened inhibitor sonidegib in combination with paclitaxel in patients with advanced solid tumors

Safety, tolerability and pharmacokinetics of intravenous ghrelin for cancer-related anorexia cachexia: a randomised, placebo-controlled, double-blind, double-crossover study

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02)

Cost of skeletal complications from bone metastases in six European countries

Severe drug-induced thrombocytopenia after treatment with trastuzumab but not with lapatinib

Fatigue and menopausal symptoms in women with breast cancer undergoing hormonal cancer treatment

The effect of real-time electronic monitoring of patient-reported symptoms and clinical syndromes in outpatient workflow of medical oncologists: E-MOSAIC, a multicenter cluster-randomized phase III study (SAKK 95/06)

Bevacizumab continuation versus no continuation after first-line chemotherapy plus bevacizumab in patients with metastatic colorectal cancer: a randomized phase III non-inferiority trial (SAKK 41/06)

Phase I study of olaparib in combination with liposomal doxorubicin in patients with advanced solid tumours

Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial

Patient-centered, self-funding dose optimization trials as a route to reduce toxicity, lower cost, and improve access to cancer therapy

Quality of life in patients treated with aflibercept and FOLFIRI for metastatic colorectal cancer: interim analysis with focus on therapy lines of the non-interventional study QoLiTrap (AIO-LQ-0113)

Combination of trastuzumab and letrozole after resistance to sequential trastuzumab and aromatase inhibitor monotherapies in patients with estrogen receptor-positive, HER-2-positive advanced breast cancer: a proof-of-concept trial (SAKK 23/03)

Lurbinectedin as second- or third-line palliative therapy in malignant pleural mesothelioma: an international, multi-centre, single-arm, phase II trial (SAKK 17/16)

Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label study

Absence of evidence is not evidence of absence: the case of non-inferiority

Interim analysis of the non-interventional study QoLiTrap (AIO-LQ-0113) in patients with metastatic colorectal cancer (mCRC) treated with aflibercept (AFL) + FOLFIRI: Efficacy according to age group ≤65 and >65 years

Real-time PCR of CD146 mRNA in peripheral blood enables the relative quantification of circulating endothelial cells and is an indicator of angiogenesis

Quality-of-life in patients with metastatic colorectal cancer (mCRC) treated with aflibercept and FOLFIRI: Interim results of the non-interventional AIO study QoLiTrap

Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

A randomized phase II study evaluating different maintenance schedules of nab-paclitaxel in the first-line treatment of metastatic breast cancer: final results of the IBCSG 42-12/BIG 2-12 SNAP trial

First-line temozolomide combined with bevacizumab in metastatic melanoma: a multicentre phase II trial (SAKK 50/07)

Suchergebnisse filtern